Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
13.82
-0.38 (-2.68%)
Apr 23, 2026, 4:00 PM EDT - Market closed
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 624 employees as of December 31, 2025. The number of employees increased by 5 or 0.81% compared to the previous year.
Employees
624
Change (1Y)
5
Growth (1Y)
0.81%
Revenue / Employee
$443,872
Profits / Employee
-$95,351
Market Cap
2.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 624 | 5 | 0.81% |
| Dec 31, 2024 | 619 | -90 | -12.69% |
| Dec 31, 2023 | 709 | -81 | -10.25% |
| Dec 31, 2022 | 790 | -68 | -7.93% |
| Dec 31, 2021 | 858 | 236 | 37.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| Ocular Therapeutix | 325 |
| Zymeworks | 264 |
| Day One Biopharmaceuticals | 178 |
| Stoke Therapeutics | 170 |
| Aurinia Pharmaceuticals | 128 |
| Definium Therapeutics | 106 |
ADPT News
- 8 days ago - Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026 - GlobeNewsWire
- 2 months ago - Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 3 months ago - Adaptive Biotechnologies spinout raising $15M to develop clinical sequencing tech - GeekWire
- 4 months ago - Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million - Reuters